• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

SPARCL1 Rekombinanter Antikörper

SPARCL1 Rekombinant Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

250331C1

Kat-Nr. : 85906-4-PBS

Synonyme

Hevin, MAST 9, PIG33, SC1, SPARC like 1 (hevin)

Filter:
  • Western Blot (WB) analysis of various lysates using SPARCL1 Recombinant antibody (85906-4-RR)

    WB analysis using 85906-4-RR (same clone as 85906-4-PBS)

    Various lysates were subjected to SDS PAGE followed by western blot with 85906-4-RR (SPARCL1 antibody) at dilution of 1:5000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 85906-4-PBS in a different storage buffer formulation.

Geprüfte Anwendungen

Produktinformation

85906-4-PBS bindet in WB, Indirect ELISA SPARCL1 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen SPARCL1 fusion protein Eg2837
Vollständiger Name SPARC-like 1 (hevin)
Berechnetes Molekulargewicht75 kDa
Beobachtetes Molekulargewicht 130-140 kDa
GenBank-ZugangsnummerNM_004684.5
Gene symbol SPARCL1
Gene ID (NCBI) 8404
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

SPARC-like protein 1 (SPARCL1), also known as SC1 or Hevin, is an extracellular matrix glycoprotein that belongs to the SPARC family. SPARCL1 is widely expressed in normal and cancer tissues, and has been shown to regulate cellular adhesion and migration. SPARCL1 has been implicated in tumor initiation, formation, and progression of various cancers, including pancreatic, prostate, bladder, ovarian, breast and non-small cell lung cancers.